Delivery Order SPE2DR25D2213-SPE2DR26F6DAC
- Not listed
- The Defense Logistics Agency awarded a $5,991.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Calcium Gluconate 1,000 mg/10 mL vials on December 1, 2025, with an ultimate completion date of December 2, 2025. This is a non-set-aside competitive award for pharmaceutical delivery to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Calcium Gluconate 10,000 mg/100 ml in 100 ml units, with a ceiling value of $1,167.16 and an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,844.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Calcium Gluconate 1,000 mg/10 ml vials (10 ml units) with an ultimate completion date of September 8, 2025. This non-set-aside competitive award was issued on September 5, 2025, with performance to be completed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $9,357.91 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of calcium gluconate 10% solution in 10 mL vials (quantity: 25 units). The contract, designated as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, was awarded on a competitive basis without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract is for the delivery of Calcium Gluconate 1,000 mg/10 ml vials, with a potential value of $1,075.68 and a completion date of February 21, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp serves as the prime...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,855.59, is for the delivery of Calcium Gluconate 1,000 mg/10 ml vials. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.78 to AmerisourceBergen Drug Corp for calcium chloride 1 gram per 10 milliliter syringes (10 milliliter units) on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- This is a $1,262.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4567678492 - CALCIUM GLUC 1,000 MG/10 ML VL 10ML, with a period of performance ending on March 25, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Calcium Chloride 1 GM/10ML syringes totaling $1,876.56. This non-set-aside, firm fixed-price delivery order represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor will fulfill this order from its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calcium Chloride 1 GM/10ML syringes valued at $1,149.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2213Indefinite Delivery Contract
- SPE2DR25D2213-SPE2DR26F6DACDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Calcium Gluconate 1,000 mg/10 mL vials on December 9, 2025, with a ceiling value of $2,065.83 and a completion date of December 10, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a pharmaceutical supply need fulfilled through the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement needs across multiple therapeutic domains for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard, demonstrating its capacity to meet critical pharmaceutical supply requirements across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/8/25 |